This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why These Tech ETFs Are Worth Buying Now
by Sweta Killa
The technology sector suffered big losses last month due to a decline in mega-cap market caps. The beaten-down prices could be viewed as solid entry points.
Here's Why COVID-Themed ETFs May Come Back Under the Radar
by Sanghamitra Saha
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.'
5 ETF Predictions for 2022
by Sweta Killa
Here are some predicted trends for the ETF world that may influence the industry in 2022.
ETF Areas Making Good Bets Amid Rising Omicron Threats
by Sweta Jaiswal, FRM
Considering the complexities of the current market scenario, let's take a look at some ETF areas that can make good investment choices.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
by Sanghamitra Saha
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
Bet On COVID-Themed ETFs as New Cases Rise Globally
by Sweta Jaiswal, FRM
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
6 Stay-at-Home ETFs Likely to Gain on Renewed Lockdown Fears
by Sanghamitra Saha
COVID-19 lockdowns in Europe once again stirred fears of further spread of infections. This raises the chances of another wave of COVID-19 in other parts of the world, which could boost the demand for stay-at-home stocks and ETFs.
5 Top ETF Stories of Nine Months of 2021
by Sweta Killa
We discuss some of the hot events of the first nine months of this year that influenced the market in a big way.
ETFs to Win & Lose as Delta Variant Cases Surge
by Sweta Killa
We have highlighted some ETFs from various corners of the space that are expected to win and lose from the surging pandemic.
The Zacks Analyst Blog Highlights: WCLD, ICLN, WFH, ITB and PSCD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: WCLD, ICLN, WFH, ITB and PSCD
5 Top-Ranked ETFs to Buy on the Dip
by Sweta Killa
The beaten down prices offer a solid buying opportunity for investors. We have highlighted five ETFs from different sectors that have declined last week on market woes but have a solid Zacks ETF Rank #1 (Strong Buy) or #2 (Buy).
Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases
by Sweta Jaiswal, FRM
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
Best ETF Areas for Placing Your Bets in September
by Sweta Jaiswal, FRM
Let's take a look at some ETF areas that can be good investment options for September.
ETF Investing Areas to Consider for August
by Sweta Jaiswal, FRM
Let's take a look at some ETF areas that can be good investment options for August.
The Zacks Analyst Blog Highlights: ARKW, WCLD, IBUY, SUBZ, WFH and IWFH
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ARKW, WCLD, IBUY, SUBZ, WFH and IWFH
Are COVID-Themed ETFs Back in Focus as Delta Variant Fears Rise?
by Sweta Jaiswal, FRM
The rest of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
Delta Variant to Spark Rally in Stay-At-Home ETFs
by Sweta Killa
After declining sharply for six months, the COVID-19 infection has resurged across the United States and around the world thanks to the new Delta variant.
What's in Store for COVID-Themed ETFs as New Cases Rise?
by Sweta Jaiswal, FRM
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart pick.
COVID-Themed ETFs in Focus Amid Soaring Cases
by Sweta Jaiswal, FRM
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
COVID-Themed ETFs in Focus as Cases Soar Post Thanksgiving
by Sweta Jaiswal, FRM
The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
COVID-19 Cases on the Rise: ETFs to Bet On
by Sweta Killa
The resurge in COVID-19 cases has put the e-commerce segment on the spotlight once again.
ETF Strategies to Play as Coronavirus Outbreak Aggravates
by Sweta Jaiswal, FRM
As the number of coronavirus cases continue to rise, we highlight some ETF strategies that can help investors sail smoothly in these turbulent times.
Coronavirus-Themed ETFs in Focus as the Pandemic Worsens
by Sweta Jaiswal, FRM
The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.
Trump vs. Biden First Presidential Debate: ETFs in Focus
by Sweta Killa
After months of campaign, President Donald Trump and Democratic nominee Joe Biden will come face-to-face on debate stage on Sep 30 in Cleveland.
5 Coronavirus-Themed ETFs That Can Fight the Pandemic Scares
by Sweta Jaiswal, FRM
It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.